Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer

Nature Genetics

Volumn 40, Issue 6, 2008, Pages 730-740

  Sakamoto, Hiromi ^a   Yoshimura, Kimio ^a,b   Saeki, Norihisa ^a,b   Katai, Hitoshi ^c   Shimoda, Tadakazu ^c   Matsuno, Yoshihiro ^c   Saito, Daizo ^c   Sugimura, Haruhiko ^d   Tanioka, Fumihiko ^e   Kato, Shunji ^f   Matsukura, Norio ^f   Matsuda, Noriko ^f   Nakamura, Tsuneya ^g   Hyodo, Ichinosuke ^h,s   Nishina, Tomohiro ^h   Yasui, Wataru ⁱ   Hirose, Hiroshi ^b   Hayashi, Matsuhiko ^b   Toshiro, Emi ^c   Ohnami, Sumiko ^a   Sekine, Akihiro ^a,b   Sato, Yasunori ^a   Totsuka, Hirohiko ^k   Ando, Masataka ^l   Takemura, Ryo ^m   Takahashi, Yoriko ⁿ   Ohdaira, Minoru ⁿ   Aoki, Kenichi ⁿ   Honmyo, Izumi ⁿ   Chiku, Suenori ^o   Aoyagi, Kazuhiko ^a   Sasaki, Hiroki ^a   Ohnami, Shumpei ^a   Yanagihara, Kazuyoshi ^a   Yoon, Kyong Ah ^p   Kook, Myeong Cherl ^p   Lee, Yeon Su ^p   Park, Sook Ryun ^p   Kim, Chan Gyoo ^p   Choi, Il Ju ^p   Yoshida, Teruhiko ^a   Nakamura, Yusuke ^j,q   Hirohashi, Setsuo ^r   more..

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Iwata City Hospital   (Japan)

^f NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

ⁱ HIROSHIMA UNIVERSITY   (Japan)

^j INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^k Research and Development Center   (Japan)

^l NEC CORPORATION   (Japan)

^m Kuramae Orashion Bldg 9F   (Japan)

ⁿ Mitsui Knowledge Industry Co   (Japan)

^o MIZUHO INFORMATION AND RESEARCH INSTITUTE   (Japan)

^p National Cancer Center   (South Korea)

^q THE UNIVERSITY OF TOKYO   (Japan)

^r NATIONAL CANCER CENTER   (Japan)

^s UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE STEM CELL ANTIGEN;

ADULT; ALLELE; ARTICLE; CELL PROLIFERATION; FEMALE; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ANIMALS; CARCINOMA, PAPILLARY; CARCINOMA, SIGNET RING CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; EPITHELIUM; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; JAPAN; KOREA; LINKAGE DISEQUILIBRIUM; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 44349178008     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.152     Document Type: Article

References (49)

1. Crew, K.D. & Neugut, A.I. Epidemiology of gastric cancer. World J. Gastroenterol. 12, 354-362 (2006).
2. Ushijima, T. & Sasako, M. Focus on gastric cancer. Cancer Cell 5, 121-125 (2004).
3. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31-49 (1965).
4. Hohenberger, P. & Gretschel, S. Gastric cancer. Lancet 362, 305-315 (2003).
5. Saito, A., Shimoda, T., Nakanishi, Y., Ochiai, A. & Toda, G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol. Int. 51, 165-171 (2001).
6. Machado, J.C. et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab. Invest. 79, 459-465 (1999).
7. Schier, S. & Wright, N.A. Stem cell relationships and the origin of gastrointestinal cancer. Oncology 69(Suppl. 1), 9-13 (2005).
8. Rosai, J. in Rosai and Ackerman's Surgical Pathology, Ch. 11, Gastrointestinal tract - stomach 648-711 (Mosby, Edinburgh, 2004).
9. Japanese Gastric Cancer Association Registration Committee. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9, 51-66 (2006).
10. Yokota, T. et al. Borrmann's type IV gastric cancer: clinicopathologic analysis. Can. J. Surg. 42, 371-376 (1999).
11. Henson, D.E., Dittus, C., Younes, M., Nguyen, H. & Albores-Saavedra, J. Differential trend in the intestinal and diffuse types of gastric carcinoma in United States, 1973-2000 - increase in the signet ring cell type. Arch. Pathol. Lab. Med. 128, 765-770 (2004).
12. Shinmura, K. et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 20, 1127-1131 (1999).
13. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85 (2000).
14. Correa, P. & Shiao, Y.-H. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. 54 (7 Suppl.), 1941s-1943s (1994).
15. González, C.A., Sala, N. & Capellá, G. Genetic susceptibility and gastric cancer risk. Int. J. Cancer 100, 249-260 (2002).
16. Hirakawa, M. et al. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res. 30, 158-162 (2002).
17. Haga, H., Yamada, R., Nakamura, Y. & Tanaka, T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J. Hum. Genet. 47, 605-610 (2002).
18. Yoshida, T. & Yoshimura, K. Outline of disease gene hunting approaches in the Millennium Genome Project of Japan. Proc. Jpn. Acad. 79, 34-50 (2003).
19. Kato, N. et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum. Mol. Genet. 17, 617-627 (2008).
20. Reiter, R.E. et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA 95, 1735-1740 (1998).
21. Gu, Z. et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19, 1288-1296 (2000).
22. Bahrenberg, G., Brauers, A., Joost, H.-G. & Jakse, G. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigen, in bladder, esophagus, and stomach tumors. Biochem. Biophys. Res. Commun. 275, 783-788 (2000).
23. Sato, Y. et al. Designing a multistage, SNP-based, genome screen for common diseases. J. Hum. Genet. 49, 669-676 (2004).
24. Karam, S. & Leblond, C.P. Origin and migratory pathways of the eleven epithelial cell types present in the body of the mouse stomach. Microsc. Res. Tech. 31, 193-214 (1995).
25. Karam, S.M., Straiton, T., Hassen, W.M. & Leblond, C.P. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells 21, 322-336 (2003).
26. Fukaya, M. et al. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 131, 14-29 (2006).
27. Saffran, D.C. et al. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl. Acad. Sci. USA 98, 2658-2663 (2001).
28. Gu, Z., Yamashiro, J., Kono, E. & Reiter, R.E. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res. 65, 9495-9500 (2005).
29. Wang, G.-Y., Lu, C.-Q., Zhang, R.-M., Hu, X.-H. & Luo, Z.W. The E-cadherin gene polymorphism -160C/A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am. J. Epidemiol. 167, 7-14 (2008).
30. Humar, B. et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 21, 8192-8195 (2002).
31. Pharoah, P.D. et al. CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer. Int. J. Cancer 101, 196-197 (2002).
32. Smith, M.G., Hold, G.L., Tahara, E. & El-Omar, E.M. Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12, 2979-2990 (2006).
33. Sasazuki, S. et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol. Biomarkers Prev. 15, 1341-1347 (2006).
34. Kamangar, F., Cheng, C., Abnet, C.C. & Rabkin, C.S. Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 1920-1928 (2006).
35. Tran, C.P., Lin, C., Yamashiro, J. & Reiter, R.E. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol. Cancer Res. 1, 113-121 (2002).
36. Sharom, F.J. & Radeva, G. GPI-anchored cleavage in the regulation of transmembrane signals. in Subcellular Biochemistry, Volume 37: Membrane Dynamics and Domains (ed. Quinn, P.J.) 285-315 (Kluwer Academic/Plenum Publishers, New York, 2004).
37. De Nooij-van Dalen, A.G. et al. Characterization of the human LY-6 antigens, the newly annotated member LY-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int. J. Cancer 103, 768-774 (2003).
38. Pharoah, P.D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33-36 (2002).
39. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. - 2nd English edition Gastric Cancer 1, 10-24 (1998).
40. Fenoglio-Preiser, C. et al. Gastric carcinoma. in WHO Classification of Tumours: Tumours of the Digestive System (eds. Hamilton, S.R. & Aaltonen, L.A.) 39-52 (IARC Press, Lyon, 2000).
41. Noguchi, M., Furuya, S., Takeuchi, T. & Hirohashi, S. Modified formalin and methanol fixation methods for molecular biological and morphological analyses. Pathol. Int. 47, 685-691 (1997).
42. Ohnishi, Y. et al. A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet. 46, 471-477 (2001).
43. Hirschhorn, J.N. & Daly, M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108 (2005).
44. Epstein, M.P. & Satten, G.A. Inference on haplotype effects in case-control studies using unphased genotype data. Am. J. Hum. Genet. 73, 1316-1329 (2003).
45. Falush, D., Stephens, M. & Pritchard, J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
46. Bacanu, S.-A., Devlin, B. & Roeder, K. The power of genomic control. Am. J. Hum. Genet. 66, 1933-1944 (2000).
47. Zhu, X., Zhang, S., Zhao, H. & Cooper, R.S. Association mapping, using a mixture model for complex traits. Genet. Epidemiol. 23, 181-196 (2002).
48. Nei, M. Molecular Evolutionary Genetics (Columbia University Press, New York, 1987).
49. Saeki, N. et al. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene 26, 6488-6498 (2007).